Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tourmaline Bio, Inc. - Common Stock
(NQ:
TRML
)
47.98
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tourmaline Bio, Inc. - Common Stock
< Previous
1
2
Next >
This New Mountain Finance Analyst Turns Bearish; Here Are Top 3 Downgrades For Monday
↗
September 15, 2025
Via
Benzinga
Unusual volume stocks in Thursday's session
↗
September 11, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via
Chartmill
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark
↗
September 10, 2025
U.S. markets closed higher on Tuesday, buoyed by fresh labor data signaling a cooling job market—potentially paving the way for Fed rate cuts. Nebius soared nearly 50% on a multibillion-dollar AI-cloud...
Via
Chartmill
Topics
Economy
Let's take a look at the stocks that are in motion in today's session.
↗
September 09, 2025
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened
↗
September 09, 2025
Via
Stocktwits
Dow Surges Over 100 Points; Korn Ferry Earnings Top Views
↗
September 09, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 09, 2025
Via
Benzinga
Tourmaline Bio, QMMM Holdings, Teck Resources And Other Big Stocks Moving Higher On Tuesday
↗
September 09, 2025
Via
Benzinga
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
↗
September 09, 2025
Novartis agreed to buy a cardiovascular-focused biotech company
Via
Investor's Business Daily
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion
↗
September 09, 2025
Tourmaline Bio shares skyrocketed Tuesday after Novartis agreed to buy the cardiovascular-focused biotech company.
Via
Investor's Business Daily
Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition
↗
September 09, 2025
Novartis agreed to acquire Tourmaline Bio for $1.4 billion as pacibekitug shows strong trial results for inflammation and cardiovascular risk reduction.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 09, 2025
Via
Benzinga
Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
↗
September 09, 2025
Via
Benzinga
Tourmaline Bio Reports Loss as R&D Rises
↗
August 13, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 23, 2025
Via
Benzinga
Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings
↗
May 20, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 20, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
Trip.com Posts Weak Earnings, Joins Vipshop, Viking Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
May 20, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
April 17, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 17, 2025
Via
Benzinga
This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
↗
March 06, 2025
Via
Benzinga
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
February 24, 2025
Via
Benzinga
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q2 2024
↗
August 08, 2024
TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024
↗
May 13, 2024
TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 21, 2024
Via
Benzinga
Dow Jumps 200 Points; US Weekly Jobless Claims Fall
↗
March 21, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.52% to 39,718.37 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 21, 2024
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via
Benzinga
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
↗
March 21, 2024
Investors saw Chugai's experimental drug as a potential rival to Argenx's approved medicine, Vyvgart.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 21, 2024
Via
Benzinga
Five Below Posts Q4 Results, Joins LexinFintech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
March 21, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Thursday.
Via
Benzinga
Topics
Stocks
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
